If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 39 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Monoclonal Gammopathy of Undetermined Significance Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
Denmark Medicine & Life Sciences
Survival Medicine & Life Sciences
Population Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 1998 2020

Strategies to improve patient-reported outcome completion rates in longitudinal studies

Nielsen, L. K., King, M., Möller, S., Jarden, M., Andersen, C. L., Frederiksen, H., Gregersen, H., Klostergaard, A., Steffensen, M. S., Pedersen, P. T., Hinge, M., Frederiksen, M., Jensen, B. A., Helleberg, C., Mylin, A. K. & Abildgaard, N., 2020, In : Quality of Life Research. 29, 2, p. 335–346

Research output: Contribution to journalJournal articleResearchpeer-review

Longitudinal Studies
Patient Outcome Assessment
Multiple Myeloma
Patient Reported Outcome Measures
Multicenter Studies
2 Citations (Scopus)
44 Downloads (Pure)

Clarithromycin added to Bortezomib-Cyclophosphamide-Dexamethasone impairs health-related quality of life in multiple myeloma patients

Nielsen, L. K., Klausen, T. W., Jarden, M., Frederiksen, H., Vangsted, A. J., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, C. L., Abildgaard, N. & Gregersen, H., Jan 2019, In : European Journal of Haematology. 102, 1, p. 70-78 9 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Clarithromycin
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Quality of Life
3 Citations (Scopus)
189 Downloads (Pure)

Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma

Nielsen, T., Kristensen, S. R., Gregersen, H., Teodorescu, E. M., Christiansen, G. & Pedersen, S., 2019, In : PLOS ONE. 14, 1, e0210835.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
myeloma
Thromboplastin
Multiple Myeloma
Phospholipids
phospholipids
2 Citations (Scopus)

The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., Helleberg, C. & Vangsted, A. J., Feb 2019, In : Leukemia. 33, 2, p. 546-549 4 p.

Research output: Contribution to journalLetterResearchpeer-review

3 Citations (Scopus)
142 Downloads (Pure)

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, C. L., Klausen, T. W., Vangsted, A. J. & Abildgaard, N., 2018, In : Experimental Hematology & Oncology. 7, 8 p., 18.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Melphalan
Clarithromycin
Multiple Myeloma
Stem Cells
Placebos

Activities 2007 2011

  • 5 Conference organisation or participation
  • 5 Talks and presentations in private or public companies
  • 3 Board duties in companies, associations, or public organisations

Bestyrelsen i Dansk Hæmatologisk Selskab (DHS) (External organisation)

Henrik Gregersen (Member)
1 Mar 2011 → …

Activity: MembershipsBoard duties in companies, associations, or public organisations

52nd Annual Meeting and Exposition of the American Society of Hematology

Henrik Gregersen (Participant)
4 Dec 20107 Dec 2010

Activity: Attending an eventConference organisation or participation

Risikofaktorer for DVT og deres betydning for varigheden af AK-behandling

Henrik Gregersen (Lecturer)
23 Nov 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Staff Meeting, Aalborg Sygehus, Auditoriet i Medicinerhuset

Henrik Gregersen (Speaker)
23 Nov 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Myelomatose: Fra diagnostik til behandling

Henrik Gregersen (Lecturer)
10 Sep 2010

Activity: Talks and presentationsTalks and presentations in private or public companies

Press / Media

Carfilzomib forlænger tiden til tilbagefald for patienter med myelomatose

Henrik Gregersen

10/12/2019

1 item of Media coverage

Press/Media: Press / Media